Polycystic Ovary Syndrome Treatment means treatment of  a common hormonal endocrine disorder that affects women of child bearing age (15 to 49 years). This disease is characterized by the formation of cysts on the ovaries leading to an insufficiency of the ovulation initiating hormone in the female body.
This report contains market size and forecasts of Polycystic Ovary Syndrome Treatment in Global, including the following market information:
Global Polycystic Ovary Syndrome Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Polycystic Ovary Syndrome Treatment market was valued at 3848.6 million in 2021 and is projected to reach US$ 4710.4 million by 2028, at a CAGR of 2.9% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Contraceptives Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Polycystic Ovary Syndrome Treatment include Sanofi, Novartis AG, Teva Pharmaceutical Industries Limited , Addex Therapeutics Ltd. , BIOCAD, Merck KGaA, AstraZeneca plc., Bristol Myers Squibb Co.  and Ferring Pharmaceuticals, Inc. and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Polycystic Ovary Syndrome Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Polycystic Ovary Syndrome Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Polycystic Ovary Syndrome Treatment Market Segment Percentages, by Type, 2021 (%)
Oral Contraceptives
Insulin Sensitizing Agents
Anti-Depressants
Ornithine Decarboxylase Inhibitors
Aromatase Inhibitors
Diuretics
Global Polycystic Ovary Syndrome Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Polycystic Ovary Syndrome Treatment Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Drug Stores
Global Polycystic Ovary Syndrome Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Polycystic Ovary Syndrome Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Polycystic Ovary Syndrome Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Polycystic Ovary Syndrome Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Novartis AG
Teva Pharmaceutical Industries Limited 
Addex Therapeutics Ltd. 
BIOCAD
Merck KGaA
AstraZeneca plc.
Bristol Myers Squibb Co. 
Ferring Pharmaceuticals, Inc.
Crinetics Pharmaceuticals, Inc.